Home › Trial NCT00662688
Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer
- Trial IDNCT00662688
- StatusTerminated
- PhasePhase 3
- Study typeInterventional
- SponsorGERCOR - Multidisciplinary Oncology Cooperative Group
- Enrollment42
- Start date2007-10
- ConditionsChemotherapeutic Agent Toxicity · Pancreatic Cancer · Thromboembolism
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.